Browsing Tag
ATEV
2 posts
Is ATEV the first scalable alternative to autologous fistulas in hemodialysis access
Can Humacyte, Inc. turn ATEV into a viable dialysis access alternative? Dive into Phase 3 signals, risks, and market impact shaping its future.
FDA extends review period for Humacyte’s vascular trauma treatment ATEV
The U.S. Food and Drug Administration’s review of Humacyte, Inc.’s innovative vascular trauma treatment, known as the acellular…